Publications
A prospective phase 2/3 study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A sub-analysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging.
Durack, JC,
Alva, AS,
Preston, MA,
Pouliot, F,
Saperstein, L,
Carroll, PR,
Pienta, KJ,
Rowe, SP,
Patnaik, A,
Probst, S,
Stambler, N,
Jensen, J,
Wong, V,
Siegel, BA,
Morris, MJ,
Journal of Clinical Oncology, 2021 May; DOI:10.1200/jco.2021.39.15_suppl.e17003 Detection of prognostic cancer-specific circular RNA in plasma.
Brown, J,
Shah, P,
Vo, J,
Tsodikov, A,
Kleyman, L,
Cao, X,
Chinnaiyan, A,
Journal of Clinical Oncology, 2021 May; DOI:10.1200/jco.2021.39.15_suppl.3032 Outcomes with novel combinations in non-clear cell renal cell carcinoma(nccRCC): ORACLE study.
Kilari, D,
Szabo, A,
Ghatalia, P,
Rose, TL,
Weise, N,
Tucker, MD,
Nelson, AA,
Dong, H,
Hester, D,
Acharya, L,
Jain, RK,
Maughan, BL,
Alva, AS,
Tripathi, A,
Basu, A,
Koshkin, VS,
Emamekhoo, H,
Davis, NB,
Desai, A,
McKay, RR,
Journal of Clinical Oncology, 2021 May; DOI:10.1200/jco.2021.39.15_suppl.4580 HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells
Xia, L,
Wen, L,
Qin, Y,
Dobson, HE,
Zhang, T,
Comer, FI,
Hinrichs, MJ,
Oberst, MD,
Coats, SR,
Chang, AE,
Liu, Y,
Bao, Y,
Dai, F,
Wicha, MS,
Li, Q,
Cell Chem Biol, 2021 May; DOI:10.1016/j.chembiol.2021.02.013 Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047 (CA224-047).
Lipson, EJ,
Tawbi, HA-H,
Schadendorf, D,
Ascierto, PA,
Matamala, L,
Gutiérrez, EC,
Rutkowski, P,
Gogas, H,
Lao, CD,
de Menezes, JJ,
Dalle, S,
Arance, AM,
Grob, J-J,
Srivastava, S,
Abaskharoun, M,
Simonsen, KL,
Li, B,
Long, GV,
Hodi, FS,
Journal of Clinical Oncology, 2021 May; DOI:10.1200/jco.2021.39.15_suppl.9503 Response and outcomes to immune checkpoint inhibitors (ICI) in advanced urothelial cancer (aUC) based on prior intravesical BCG.
Talukder, R,
Makrakis, D,
Castellano, D,
Koshkin, VS,
Alva, AS,
Stewart, TF,
Santos, VS,
Jain, J,
Morales-Barrera, R,
Grant, M,
Nelson, AA,
Shreck, E,
Sankin, A,
Zakopoulou, R,
Rodriguez-Vida, A,
Liu, S,
Fröbe, A,
Di Lorenzo, G,
Grivas, P,
Khaki, AR,
Journal of Clinical Oncology, 2021 May; DOI:10.1200/jco.2021.39.15_suppl.4537 CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma.
Wolchok, JD,
Chiarion-Sileni, V,
Gonzalez, R,
Grob, J-J,
Rutkowski, P,
Lao, CD,
Cowey, CL,
Schadendorf, D,
Wagstaff, J,
Dummer, R,
Ferrucci, PF,
Smylie, M,
Butler, MO,
Hill, AG,
Marquez-Rodas, I,
Haanen, JBAG,
Bas, T,
van Dijck, W,
Larkin, J,
Hodi, FS,
Journal of Clinical Oncology, 2021 May; DOI:10.1200/jco.2021.39.15_suppl.9506 Survival outcomes associated with fewer combination ipilimumab/nivolumab doses in advanced-stage melanoma.
T, V,
Sun, Y,
Sitto, M,
Waninger, J,
Fecher, LA,
Green, M,
Lao, CD,
Journal of Clinical Oncology, 2021 May; DOI:10.1200/jco.2021.39.15_suppl.9549 Mental health care utilization among veterans with castration-resistant prostate cancer receiving abiraterone or enzalutamide.
Tsao, PA,
Burns, JA,
Entenman, S,
Kumbier, K,
Sparks, J,
Bohnert, ASB,
Skolarus, TA,
Caram, MV,
Journal of Clinical Oncology, 2021 May; DOI:10.1200/jco.2021.39.15_suppl.e18680 Ultra-Rapid Somatic Variant Detection via Real-Time Threshold Sequencing
Wadden, J,
Newell, B,
Bugbee, J,
Dickson, R,
Koschmann, C,
Blaauw, D,
Narayanasamy, S,
Das, R,
2021 May; DOI:10.1101/2021.05.14.444172 Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
Rogawski, DS,
Deng, J,
Li, H,
Miao, H,
Borkin, D,
Purohit, T,
Song, J,
Chase, J,
Li, S,
Ndoj, J,
Klossowski, S,
Kim, E,
Mao, F,
Zhou, B,
Ropa, J,
Krotoska, MZ,
Jin, Z,
Ernst, P,
Feng, X,
Huang, G,
Nishioka, K,
Kelly, S,
He, M,
Wen, B,
Sun, D,
Muntean, A,
Dou, Y,
Maillard, I,
Cierpicki, T,
Grembecka, J,
Nat Commun, 2021 May; DOI:10.1038/s41467-021-23152-6 Identifying risk factors and patterns for early recurrence of pancreatic neuroendocrine tumors: A multi-institutional study
Heidsma, CM,
Tsilimigras, DI,
Rocha, F,
Abbott, DE,
Fields, R,
Poultsides, GA,
Cho, CS,
Lopez-Aguiar, AG,
Kanji, Z,
Fisher, AV,
Krasnick, BA,
Idrees, K,
Makris, E,
Beems, M,
van Eijck, CHJ,
Nieveen van Dijkum, EJM,
Maithel, SK,
Pawlik, TM,
Cancers (Basel), 2021 May; DOI:10.3390/cancers13092242 415 Risk of Obstructive Sleep Apnea after Treatment of Head and Neck Squamous Cell Carcinoma
Gavidia, R,
Dunietz, GL,
O’Brien, L,
Schütz, S,
Spector, M,
Swiecicki, P,
Chervin, R,
Sleep, 2021 May; DOI:10.1093/sleep/zsab072.414 Virus-positive Merkel cell carcinoma is an independent prognostic group with distinct predictive biomarkers
Harms, KL,
Zhao, L,
Johnson, B,
Wang, X,
Carskadon, S,
Palanisamy, N,
Rhodes, DR,
Mannan, R,
Vo, JN,
Choi, JE,
Chan, MP,
Fullen, DR,
Patel, RM,
Siddiqui, J,
Ma, VT,
Hrycaj, S,
McLean, SA,
Hughes, TM,
Bichakjian, CK,
Tomlins, SA,
Harms, PW,
Clin Cancer Res, 2021 May; DOI:10.1158/1078-0432.CCR-20-0864 Diffusion-Weighted Imaging of the Head and Neck (Including Temporal Bone)
Boucher, F,
Liao, E,
Srinivasan, A,
Magn Reson Imaging Clin N Am, 2021 May; DOI:10.1016/j.mric.2021.01.005 Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett’s Esophagus
Reddy, CA,
Tavakkoli, A,
Chen, VL,
Korsnes, S,
Bedi, AO,
Carrott, PW,
Chang, AC,
Lagisetty, KH,
Kwon, RS,
Elmunzer, BJ,
Orringer, MB,
Piraka, C,
Prabhu, A,
Reddy, RM,
Wamsteker, E,
Rubenstein, JH,
Dig Dis Sci, 2021 May; DOI:10.1007/s10620-020-06377-1 The impact of BRAF mutation status on clinical outcomes with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab in treatment-naïve advanced stage melanoma
Ma, VT,
Daignault-Newton, S,
Waninger, JJ,
Journey, S,
Chopra, Z,
Tezel, A,
Redman, BG,
Fecher, LA,
Green, MD,
Alva, AS,
Lao, CD,
Pigment Cell Melanoma Res, 2021 May; DOI:10.1111/pcmr.12944 Impact of Breast Cancer Pretreatment Nodal Burden and Disease Subtype on Axillary Surgical Management
Ng, S,
Sabel, MS,
Hughes, TM,
Chang, AE,
Dossett, LA,
Jeruss, JS,
J Surg Res, 2021 May; DOI:10.1016/j.jss.2020.12.007 Dermoscopic Features of Mycosis Fungoides and Its Variants in Patients with Skin of Color: A Retrospective Analysis
Nakamura, M,
Huerta, T,
Williams, K,
Hristov, AC,
Tejasvi, T,
Dermatol Pract Concept, 2021 May; DOI:10.5826/dpc.1103a48 Cutaneous follicle center lymphomas with plasmacytic differentiation
Skala, SL,
Harms, PW,
Fullen, DR,
Brown, NA,
Tejasvi, T,
Wilcox, RA,
Boyer, DF,
Hristov, AC,
J Cutan Pathol, 2021 May; DOI:10.1111/cup.13917 OR practice-data analytics for optimal detection of metastatic prostate cancer
Merdan, S,
Barnett, CL,
Denton, BT,
Montie, JE,
Miller, DC,
Operations Research, 2021 May; DOI:10.1287/OPRE.2020.2020 Referral pattern for urologic malignancies before and during the COVID-19 pandemic
Maganty, A,
Yu, M,
Anyaeche, VI,
Zhu, T,
Hay, JM,
Davies, BJ,
Yabes, JG,
Jacobs, BL,
Urol Oncol, 2021 May; DOI:10.1016/j.urolonc.2020.11.027 Imaging Surveillance of Gliomas: Role of Basic and Advanced Imaging Techniques
Bapuraj, JR,
Perni, K,
Gomez-Hassan, D,
Srinivasan, A,
Radiol Clin North Am, 2021 May; DOI:10.1016/j.rcl.2021.01.006 Diagnosis and categorization of malignant effusions: A 6-year review from a single academic institution
Lew, M,
Cantley, R,
Heider, A,
Jing, X,
Diagn Cytopathol, 2021 May; DOI:10.1002/dc.24433 A randomized phase II study of coexpression extrapolation (COXEN) with neoadjuvant chemotherapy for bladder cancer (SWOG S1314; NCT02177695)
Flaig, TW,
Tangen, CM,
Daneshmand, S,
Alva, A,
Lerner, SP,
Lucia, MS,
McConkey, DJ,
Theodorescu, D,
Goldkorn, A,
Milowsky, MI,
Bangs, R,
MacVicar, GR,
Bastos, BR,
Fowles, JS,
Gustafson, DL,
Plets, M,
Thompson, IM,
Clin Cancer Res, 2021 May; DOI:10.1158/1078-0432.CCR-20-2409 